Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in the Emergency Department (AcuMAP)

February 20, 2020 updated by: Pr. Semir Nouira, University of Monastir

Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in the Emergency Department. An Efficacy and Safety Study

Inadequate pain management is a common problem encountered in ED settings. Pain relief medications use is often limited by their side effects. Evidence suggests that non pharmacologic pain relief techniques such as acupuncture can play a central role to treat pain in acute conditions, but their application is still scarce.

Study Overview

Status

Completed

Conditions

Detailed Description

Pain is a common cause of emergency department visits and its control remains a challenge and health priority worldwide. Many techniques were developed to control pain and to ensure patients comfort but their application is still difficult especially in emergency department (ED) settings, due to the variety of treated conditions, the non-availability of qualified practitioners and the patient's specificity. Pharmacologic methods in particular IV opioids are the most used and with regard to their rapid action with high efficacy. But the use of these drugs can be limited by their side effects. Non-pharmacologic pain relief techniques such as acupuncture have been proposed. During the second half of the twentieth century, acupuncture was established in Europe and in the last two decades, it has spread around the world. In Tunisia, acupuncture was introduced into the health system in the 90s, particularly to treat pain.

The World Health Organization (WHO) has recognized acupuncture as safe and sound therapy. A preliminary list of acupuncture indications has been reported including 43 diseases. However, the introduction of acupuncture in the treatment of pain in ED is more recent or even anecdotal. In the treatment of chronic pain, it was shown that acupuncture is comparable to morphine and that its better safety profile makes it the method of choice in some clinical conditions.

In a recent systematic review, it has been concluded that there is insufficient evidence for the use of acupuncture in the ED settings due to the paucity of randomized controlled trials and the suboptimal methodological qualities of related studies.

The aim of our study was to evaluate the efficacy and safety of acupuncture compared with morphine for the management of acute pain in ED.

Study Type

Interventional

Enrollment (Actual)

300

Phase

  • Phase 2

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Acute onset pain < 72 hours of the ED presentation
  • Pain intensity ≥ 40 of the VAS or NRS (ranging from 0 for no pain to 100 for maximum imaginable pain)
  • Acute musculoskeletal pain with no evidence of fracture or dislocation, including ankle and knee sprains without signs of severity (ligament rupture, laxity), shoulder and elbow tendinitis, upper and lower limb mechanical pains and lower back pain with no evidence of neurological deficit.
  • Acute abdominal pain with no urging surgical intervention including renal colic and dysmenorrhea.
  • Acute headache that meets the criteria of primary headache, as described by the international headache society.

Exclusion Criteria:

  • Temperature > 37.7°c
  • Violent mechanism of trauma
  • Patients under anticoagulant drugs or with coagulation abnormalities
  • Skin affections (infections, hematoma, dermatosis) that would impair the use of certain acupuncture points
  • Patients that were judged enable to participate in the study at the discretion of the treating physician.
  • Refusal, inability to consent.
  • Inability to assess the degree of pain using the VAS or NRS
  • Patients who had received analgesics in the 6 hours prior to the enrollment
  • An initial pain score ≤ 40 on the VAS or NRS
  • Patients who had presented to the ED in the last 24 hours with the same motif
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acupuncture
patients received a 20 to 30 minutes session of acupuncture
Acupuncture session of 20 to 30 minutes. Treatment protocols were determined through review of major clinical manuals and textbooks, literature review, and a panel of specialist acupuncturists from Chinese medicine backgrounds.
Active Comparator: IV Morphine
patients received an intravenous titration of morphine every 5 minutes.
Patients in this group received IV titrated morphine. Morphine was prepared onsite and diluted in a manner to obtain a dose of 1mg in each ml of normal saline. The initial dose was 0.1 mg per kg and a titration dose of 0.05 mg per Kg was repeated every 5 minutes until reaching objective. The maximum allowed dose was 1.5 mg/kg.
Other Names:
  • Morphine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of pain severity from baseline
Time Frame: 10, 20, 30, 45, 60 minutes

Change of pain score was assessed at 10, 20, 30, 45 and 60 minutes time points from the starting of the protocol.

Pain severity was measured using the visual analogic scale (VAS) going from 10 (maximum imaginable pain) to 0 (no pain). if the VAS was not applicable to certain patients, a verbal numeric rating scale (NRS) was used instead.

Success of treatment was defined by a drop in the pain intensity under 30.

10, 20, 30, 45, 60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
resolution time
Time Frame: 10, 20, 30, 45, 60 minutes
This interval was defined by the time (in minutes) elapsed between the start of the protocol (T0) and the decrease of the pain score of at least 50% of its initial value.
10, 20, 30, 45, 60 minutes
adverse events
Time Frame: 10, 20, 30, 45, 60 minutes and until ED discharge

Occurrence of major side effects implicates the immediate ending of the protocol, more particularly:

  • Allergic manifestations such as rush and generalized edema
  • severe hypotension defined by a drop of the systolic blood pressure under 90 mmHg or a loss of more than 20 mmHg of the initial systolic blood pressure
  • recurrent vomiting non controlled by the standard measures
  • Altered mental status
  • Uncontrolled bleeding from the site of needle insertion
  • Respiratory distress with capillary saturation under 95% or signs of pneumothorax
10, 20, 30, 45, 60 minutes and until ED discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

March 1, 2013

Study Registration Dates

First Submitted

May 25, 2015

First Submitted That Met QC Criteria

May 30, 2015

First Posted (Estimate)

June 3, 2015

Study Record Updates

Last Update Posted (Actual)

February 21, 2020

Last Update Submitted That Met QC Criteria

February 20, 2020

Last Verified

February 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Pain

Clinical Trials on Acupuncture

3
Subscribe